Corona virus vaccine: Has Russia developed it?
By : Samarjeet Singh | Updated On : 15 Jul, 2020
More than 13 million people have been infected with the novel coronavirus so far and nearly half a million people have died due to the disease caused by this virus. After a nearly seven-month-long outbreak of the virus, Russia has claimed that their scientists have made the first vaccine of the coronavirus.
According to Russian news agency Sputnik, Vadim Tarasov, director of the Institute for Translational Medicine and Biotechnology, said that clinical trial of the world's first corona vaccine has been successfully completed; He told that 'the Moscow-based government medical university Sechenov university conducted these trials and found that this vaccine is safe on humans. One group of people who have been tried the vaccine will be discharged from the hospital on July 15 and the other group on July 20.
On 18 June, the university began clinical trials of the vaccine produced by Russia's Gamely Institute of Epidemiology and Microbiology.
Alexander Lukashev, director of the Institute of Medical Parasitology University, said the university has made plans for further vaccine development. Now after regulatory approval of the virus, its production will start. Lukashev said that the possibility of increasing production is also being discussed. If everything goes well, the production of vaccine can start in two to three months. However, questions are arising on the Russian trial, in view of which its approval may be delayed.
Russia has claimed to have developed the vaccine but has not made it clear how the vaccine will be made available. Use of only 38 volunteers in the trial is also being questioned. In such a situation, it may be that more research is required before use. If this prototype of the vaccine goes into effect, it will be the first coronavirus vaccine available in the world. Then Russia can make rules regarding the availability of the vaccine. Because the World Health Organization is monitoring all vaccine development programs.